In addition, interestingly, the inhibitory mechanisms of cancer growth by NCL1 appeared to be related not only to the direct effects on cell proliferation but also angiogenesis, as confirmed by a reduction in CD 31-positive vessels in vivo (Fig. 6C, 6H, 6I). The gene discussed is CAPN3; the disease is cancer.